Dr. Barry brings over 20 years of strategic technical development and commercial translation of scientific products, analytical services, drug development and pre-clinical evaluation systems to his position. Prior to joining Kaneka, he co-founded and served as the president of a Massachusetts-based drug development company. Under Dr. Barry’s direction, the company identified new lead-drug candidates, focusing on unmet clinical needs in several disease areas.
He is an active member of numerous professional associations, including:
- The American Chemical Society
- The American Association for the Advancement of Science
- Mitochondria Research Society
- American Burn Association
- The International Coenzyme Q10 Association
Published Work, Presentations and Advisories
Dr. Barry has presented at nearly all Kaneka Nutrients professional venues. He was a Principal Advisor for NIH, specializing in the commercial development of biotech start-up companies, their technologies and products.
He also founded and served as president of a premier independent testing laboratory and scientific research company serving the natural products industry. Prior to that, Dr. Barry developed a natural products division for a major analytical device company where he served as vice president and chief technical officer.
Dr. Barry earned his bachelor’s degree in Biology from Boston College; his Ph.D. in Chemistry/Biochemistry from the University of Maryland; postdoctoral research in Biological Chemistry and Molecular Pharmacology at Harvard Medical School; and was a staff researcher in neuropathology at Harvard Medical School.